Skip to main content

ACADIAN ASSET MANAGEMENT LLC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 916542 Boston, MA

Position in CRVS

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,011,693
+$590,693 QoQ
Shares Held
69,152
-13.3% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CRVS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,011,693 69,152
2024-09-30 $421,000 79,735
2023-06-30 $132,978 58,069
2023-03-31 $119,911 131,771
2022-12-31 $112,005 131,771
2022-09-30 $116,429 142,160
2022-06-30 $140,738 142,160
2022-03-31 $229,793 140,118
2021-12-31 $195,610 81,166
2021-09-30 $199,558 41,231
2021-06-30 $136,113 50,979
2021-03-31 $64,482 20,936
2020-12-31 $329,307 92,502
2020-09-30 $630,107 157,134
2020-06-30 $494,373 181,755